Vident Investment Advisory, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.21 - $0.53 $2,617 - $6,606
12,466 Added 4.89%
267,612 $67,000
Q1 2022

May 16, 2022
BUY
$0.32 - $0.67 $32,530 - $68,111
101,659 Added 66.23%
255,146 $135,000
Q4 2021

Feb 14, 2022
BUY
$0.6 - $1.11 $3,824 - $7,075
6,374 Added 4.33%
153,487 $95,000
Q3 2021

Nov 12, 2021
BUY
$1.01 - $1.82 $148,584 - $267,745
147,113 New
147,113 $150,000

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $1.22B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email